Newsroom

Categories: Biotechnology, Drug Discovery & Development, Pharma

RenaSci bolsters kidney disease and fibrosis capabilities with senior appointment

January 8, 2020

Categories: Drug Discovery & Development, Pharma, Corporate, Finance & Investor

Pathios Therapeutics closes US$8.8M Series A and appoints Stuart Hughes as CEO

December 18, 2019

Categories: Materials Science, Research, Diagnostics & Hospital Laboratory, Healthcare, Energy & Environment, General Science, Computing & Technology, General Laboratory, Microscopy & Imaging, Drug Discovery & Development, Microbiology & Infection Control, Analytical Chemistry, Pharma, General Chemistry, Water, Clinical Research & Trials

The most discussed and shared scientific research of 2019

December 17, 2019

Categories: Drug Discovery & Development, Pharma, Corporate, Finance & Investor

TTP Labtech announces company name change to SPT Labtech

December 12, 2019

Categories: Diagnostics & Hospital Laboratory, Pharma, Clinical Research & Trials, Corporate, Finance & Investor

Inceptua appoints new CEO

December 11, 2019

Categories: Healthcare, Pharma, Clinical Research & Trials

Inceptua Medicines Access and Onconova Therapeutics announce pre-approval access collaboration for rigosertib

December 9, 2019

Categories: Biomanufacturing, Biotechnology, Diagnostics & Hospital Laboratory, Healthcare, Drug Discovery & Development, Pharma, Clinical Research & Trials, Corporate, Finance & Investor

Inceputua appoints new president to lead North America business development

December 5, 2019

Categories: Bioprocessing, Omics & Genetics, Biomanufacturing, Biotechnology, Diagnostics & Hospital Laboratory, Healthcare, Computing & Technology, General Laboratory, Drug Discovery & Development, Analytical Chemistry, Pharma, Clinical Research & Trials

Tangerine Medical adopts MPEG-G data format for end-to-end genomic data processing

December 3, 2019

Categories: Healthcare, Pharma, Clinical Research & Trials, Corporate, Finance & Investor, Manufacturing

Inceptua and Bendalis enter into exclusive oncology medicine supply agreement for clinical trials

November 25, 2019